NCT02376114View on ClinicalTrials.gov

Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Glaucoma, Open-Angle
Interventions
DRUG

Ginkgo biloba

The Ginkgo biloba extract that was used contained 24% ginkgo flavone glycosides and 6% terpene lactones (Vitamin Research Products, Carson City, Nevada). Patients took 60 mg of Ginkgo or a placebo twice daily by mouth for two weeks. The placebo consisted of 40 mg of corn starch. Ginkgo and the placebo were encapsulated to ensure identical appearance.

DRUG

Placebo to Ginkgo biloba

Trial Locations (1)

H1T2M4

Maisonneuve-Rosemont Hospital, Montreal

All Listed Sponsors
lead

Maisonneuve-Rosemont Hospital

OTHER

NCT02376114 - Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma | Biotech Hunter | Biotech Hunter